J
Jian Sun
Researcher at Southern Medical University
Publications - 115
Citations - 3221
Jian Sun is an academic researcher from Southern Medical University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 27, co-authored 104 publications receiving 2452 citations.
Papers
More filters
Journal ArticleDOI
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).
Jinlin Hou,Guiqiang Wang,Fu-Sheng Wang,Jun Cheng,Hong Ren,Hui Zhuang,Jian Sun,Lanjuan Li,Jie Li,Qinghua Meng,Jingmin Zhao,Zhongping Duan,Jidong Jia,Hong Tang,Jifang Sheng,Jie Peng,Fengmin Lu,Qing Xie,Lai Wei +18 more
TL;DR: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Infectiously Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing; The Institute of Translational Hepatology, 302 Hospital of PLA, P Beijing, China.
Journal ArticleDOI
Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen–negative Chinese carriers
Jinlin Hou,Zhanghui Wang,Jinjun Cheng,Yulong Lin,George K. K. Lau,Jian Sun,Fuyuan Zhou,Jenny Waters,Peter Karayiannis,Kangxian Luo +9 more
TL;DR: The existence of patients with occult HBV infection caused by HBsAg variants, therefore, has implications for their possible transmission through sexual contact and by blood transfusion.
Journal ArticleDOI
Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
TL;DR: The data suggests that HBeAg can cross the human placenta, and disappears from serum within 6 months in most babies, and HBV DNA levels in hepatitis B carrier mothers are associated with the failure of HBIG and vaccine immunization.
Journal ArticleDOI
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.
Cheng Wang,Dong Ji,Jing Chen,Qing Shao,Bing Li,Jia-Liang Liu,Vanessa Wu,April Wong,Yudong Wang,Xiaoyong Zhang,Lei Lu,Chris L P Wong,Stella T Y Tsang,Zheng Zhang,Jian Sun,Jinlin Hou,Guofeng Chen,George K. K. Lau +17 more
TL;DR: Testing positive for HBsAg before DAA treatment was a strong risk factor for developing hepatitis during treatment (hazard ratio, 15.0; P < .001).
Journal ArticleDOI
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
Rong Fan,George V. Papatheodoridis,Jian Sun,Hamish Innes,Hidenori Toyoda,Qing Xie,Shuyuan Mo,Vana Sypsa,Indra Neil Guha,Takashi Kumada,Junqi Niu,George N. Dalekos,Satoshi Yasuda,Eleanor Barnes,Jianqi Lian,Vithika Suri,Ramazan Idilman,Stephen T. Barclay,Xiaoguang Dou,Thomas Berg,Peter C. Hayes,John F. Flaherty,Yuanping Zhou,Zhengang Zhang,Maria Buti,Sharon J. Hutchinson,Yabing Guo,Jose Luis Calleja,Lanjia Lin,Longfeng Zhao,Yongpeng Chen,Harry L.A. Janssen,Chaonan Zhu,Lei Shi,Xiaoping Tang,Anuj Gaggar,Lai Wei,Jidong Jia,William L. Irving,Philip J. Johnson,Pietro Lampertico,Jinlin Hou +41 more
TL;DR: This objective, simple, reliable risk score based on five common parameters accurately predicts HCC development, regardless of aetiology and ethnicity, which may help to establish a risk score-guided HCC surveillance strategy worldwide.